RE:Coles notes from last weekThanks for taking the time to post this, Kokomak. The most useful and intelligent post I've read in days on this forum. Cheers!
kokomak wrote: To all long investors,
Yes the call was reassuring, a few key points:
- We own the name
- The name change will be done after debentures of the Dec 15, waited till then because of all the paperwork
- Patent will be filed in 2 to 4 weeks which KNR in better position to have some orders as opposed to 2 months ago some as it could have been stolen
- This permits the sell of smaller batch orders as a major lead order
- PG found out that the Ministry of Education sector don't do procurement, that it's another ministry within the gvt can't remember which one but said you can look at the lobbyist info that some have posted to see they are talking with. The MOE don't by products
- They are looking at partnerships or have been approached and if anything comes out of that obviously NR necessary (my example is a lead order in bulk and whoever the company is in turn they sell the product). Leasing has also been talked about however can't remember too much about that example
- PG has tried to keep shareholders informed however too many releases and we are considered a pump company and not enough info and you get criticized
- PG not concern of share price, yes he saw we got attacked by shorts which exist on every exchange, in short the SP will take care of itself with orders which = revenue
- The orders (revenue) will raise share price and up listing will be done down the road once we achieve the mark that is needed on the balance sheet which I can't remember what that is
- The first orders will take care of the narrative
- Distribution still set in November will announce when it takes place however no projected revenue forecasted. Doesn't want to disclosed the potential
- Website will be announced soon as he commented someone found it and posted on Twitter
- Has told the people inquiring to get behind the door in the queue with their lead order
- The other side of the business is doing good but there has been some challenges getting to some sites. Expect revenue numbers to be approximately same which is good for so much going on. Obviously revenue numbers for Biocloud will be captured in the next quarter
- Biocloud is 10-12 year life expectancy. PG doesn't want it known as a covid stock but a product that's here now and for the future.
Just thought I would share and we shall her the same on Wednesday. PG hasn't let us down yet and he himself refused to accept cheers on the roll out cause he said himself that sometimes things are going good and all of a sudden you have to take a few steps back and regroup and persevere and learn. He was very positive, calm and had a few opinions regarding the new vaccines which doesn't or shouldn't affect the company. The news is imminent and it's just a matter when the purchaser signs the dotted line I'm thinking.
I hope we can all see light at the end of the tunnel. Slow progression sometimes is better for the health of the company rather then yo-yo and constantly being shorted on swings.
Kokomak